Michael Scolaro

Michael Scolaro

Nov 10, 2017

Group 6 Copy 199
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Nepalese shrines and parks: hotspots for pathogen exchange between primates and humans?

In Nepal people and primates come into close contact where humans both intentionally and unintentionally feed...

Physical experience of emotion: an early marker of Parkinson's Disease?

At least a decade before diagnosis with Parkinson's, the disease is transforming the way the mind and the body...

Crowdcuring the Blues: People, Technology and Research Against Depression

Depression is not a choice, but we can choose to do something about it. Depression is a single label used...

Backer Badge Funded